SSPN knockdown in a cultured glioma cell line (LN-229) did not affect cell division as determined by bromodeoxyuridine (BrdU) incorporation, but did increase vulnerability of glioma cells to hypoxia [92]. Here, SSPN is linked to central nervous system cancer.